Joachim Boos - Dissemin

Language
Login

All papers authored by Joachim Boos

This paper was not found in any repository, but could be made available legally by the author.

2021 Christian Siebel

ORCID

, Claudia Lanvers-Kaminsky

ORCID

, Julia Alten, Petr Smisek

ORCID

, Christa E. Nath

ORCID

, Carmelo Rizzari

ORCID

, Joachim Boos

ORCID

, Gudrun Würthwein

ORCID

Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach

Upload

This paper is made freely available by the publisher.

2020 Christian Siebel

ORCID

, Claudia Lanvers-Kaminsky

ORCID

, Gudrun Würthwein

ORCID

ORCID

, Joachim Boos

ORCID

Bioanalysis of doxorubicin aglycone metabolites in human plasma samples–implications for doxorubicin drug monitoring

Download from www.nature.com

This paper is made freely available by the publisher.

Christian Siebel

ORCID

, Gudrun Würthwein, Claudia Lanvers-Kaminsky, Nicolas André, Frank Berthold, Ilaria Castelli, Pascal Chastagner, François Doz, Martin English, Gabriele Escherich, Michael C. Frühwald, Norbert Graf, Andreas H. Groll, Antonio Ruggiero, Georg Hempel and 1 other authors

Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure

Download from link.springer.com

This paper is made freely available by the publisher.

2018 Miriam Götte, Sabine Verena Kesting, Joachim Gerss, Dieter Rosenbaum, Joachim Boos

ORCID

Feasibility and effects of a home-based intervention using activity trackers on achievement of individual goals, quality of life and motor performance in patients with paediatric cancer

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2017 Gudrun Würthwein, Claudia Lanvers-Kaminsky, Georg Hempel, Silke Gastine

ORCID

, Anja Möricke, Martin Schrappe, Mats O. Karlsson, Joachim Boos

ORCID

Population Pharmacokinetics to Model the Time-Varying Clearance of the PEGylated Asparaginase Oncaspar® in Children with Acute Lymphoblastic Leukemia

Upload

Missing publications? Search for publications with a matching author name.